Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients

Abstract

The results suggest that baseline MxA mRNA levels may be useful for predicting whether multiple sclerosis patients will respond or not to interferon-beta treatment.